BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

197 related articles for article (PubMed ID: 22116628)

  • 1. Antifungal susceptibility, enzymatic activity, PCR-fingerprinting and ITS sequencing of environmental Cryptococcus laurentii isolates from Uberaba, Minas Gerais, Brazil.
    Ferreira-Paim K; Andrade-Silva L; Mora DJ; Lages-Silva E; Pedrosa AL; da Silva PR; Andrade AA; Silva-Vergara ML
    Mycopathologia; 2012 Jul; 174(1):41-52. PubMed ID: 22116628
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Genotyping of Cryptococcus neoformans isolated from captive birds in Uberaba, Minas Gerais, Brazil.
    Ferreira-Paim K; Andrade-Silva L; Mora DJ; Pedrosa AL; Rodrigues V; Silva-Vergara ML
    Mycoses; 2011 Sep; 54(5):e294-300. PubMed ID: 20492533
    [TBL] [Abstract][Full Text] [Related]  

  • 3. RAPD analysis with the primer L15996 of Brazilian clinical and environmental Cryptococcus neoformans isolates.
    Andrade-Silva L; Ferreira-Paim K; Mora DJ; da Silva PR; Andrade AA; Lages-Silva E; Pedrosa AL; Silva-Vergara ML
    Mycopathologia; 2012 Jul; 174(1):53-9. PubMed ID: 22249603
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Molecular typing of environmental Cryptococcus neoformans/C. gattii species complex isolates from Manaus, Amazonas, Brazil.
    Alves GS; Freire AK; Bentes Ados S; Pinheiro JF; de Souza JV; Wanke B; Matsuura T; Jackisch-Matsuura AB
    Mycoses; 2016 Aug; 59(8):509-15. PubMed ID: 27005969
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Candida haemulonii complex: species identification and antifungal susceptibility profiles of clinical isolates from Brazil.
    Ramos LS; Figueiredo-Carvalho MH; Barbedo LS; Ziccardi M; Chaves AL; Zancopé-Oliveira RM; Pinto MR; Sgarbi DB; Dornelas-Ribeiro M; Branquinha MH; Santos AL
    J Antimicrob Chemother; 2015 Jan; 70(1):111-5. PubMed ID: 25134720
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Antifungal drug susceptibility and phylogenetic diversity among Cryptococcus isolates from dogs and cats in North America.
    Singer LM; Meyer W; Firacative C; Thompson GR; Samitz E; Sykes JE
    J Clin Microbiol; 2014 Jun; 52(6):2061-70. PubMed ID: 24696030
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Molecular characterization and evaluation of virulence factors of Cryptococcus laurentii and Cryptococcus neoformans strains isolated from external hospital areas.
    Andrade-Silva L; Ferreira-Paim K; Silva-Vergara ML; Pedrosa AL
    Fungal Biol; 2010; 114(5-6):438-45. PubMed ID: 20943154
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Molecular typing and in vitro antifungal susceptibility of Cryptococcus spp from patients in Midwest Brazil.
    Favalessa OC; de Paula DA; Dutra V; Nakazato L; Tadano T; Lazera Mdos S; Wanke B; Trilles L; Walderez Szeszs M; Silva D; Hahn RC
    J Infect Dev Ctries; 2014 Aug; 8(8):1037-43. PubMed ID: 25116671
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Molecular typing and antifungal susceptibility of clinical and environmental Cryptococcus neoformans species complex isolates in Goiania, Brazil.
    Souza LK; Souza Junior AH; Costa CR; Faganello J; Vainstein MH; Chagas AL; Souza AC; Silva MR
    Mycoses; 2010 Jan; 53(1):62-7. PubMed ID: 19500261
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Microbiological characteristics of clinical isolates of Cryptococcus neoformans in Taiwan: serotypes, mating types, molecular types, virulence factors, and antifungal susceptibility.
    Liaw SJ; Wu HC; Hsueh PR
    Clin Microbiol Infect; 2010 Jun; 16(6):696-703. PubMed ID: 19694765
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Molecular identification, genotypic heterogeneity and comparative pathogenicity of environmental isolates of
    Asadzadeh M; Ahmad S; Khan Z; Verghese S; Joseph L
    J Med Microbiol; 2020 Nov; 69(11):1285-1292. PubMed ID: 32945764
    [No Abstract]   [Full Text] [Related]  

  • 12. Diversity and Antifungal Drug Susceptibility of Cryptococcus Isolates in Thailand.
    Worasilchai N; Tangwattanachuleeporn M; Meesilpavikkai K; Folba C; Kangogo M; Groß U; Weig M; Bader O; Chindamporn A
    Med Mycol; 2017 Aug; 55(6):680-685. PubMed ID: 27915307
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Molecular epidemiology and antifungal susceptibility of Candida parapsilosis sensu stricto, Candida orthopsilosis, and Candida metapsilosis in Taiwan.
    Chen YC; Lin YH; Chen KW; Lii J; Teng HJ; Li SY
    Diagn Microbiol Infect Dis; 2010 Nov; 68(3):284-92. PubMed ID: 20851551
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Susceptibility profile of clinical and environmental isolates of Cryptococcus neoformans and Cryptococcus gattii in Uberaba, Minas Gerais, Brazil.
    Andrade-Silva L; Ferreira-Paim K; Mora DJ; Da Silva PR; Andrade AA; Araujo NE; Pedrosa AL; Silva-Vergara ML
    Med Mycol; 2013 Aug; 51(6):635-40. PubMed ID: 23343452
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Misidentification of a Rare Species, Cryptococcus laurentii, by Commonly Used Commercial Biochemical Methods and Matrix-Assisted Laser Desorption Ionization-Time of Flight Mass Spectrometry Systems: Challenges for Clinical Mycology Laboratories.
    Xiao M; Fan X; Chen XX; Wang H; Zhang L; Xu ZP; Kudinha T; Kong F; Xu YC
    J Clin Microbiol; 2016 Jan; 54(1):226-9. PubMed ID: 26560541
    [TBL] [Abstract][Full Text] [Related]  

  • 16. In vitro susceptibility to antifungal agents of environmental Cryptococcus spp. isolated in the city of Ribeirão Preto, São Paulo, Brazil.
    Pedroso RS; Ferreira JC; Candido RC
    Mem Inst Oswaldo Cruz; 2006 May; 101(3):239-43. PubMed ID: 16862315
    [TBL] [Abstract][Full Text] [Related]  

  • 17. DNA fingerprinting pattern and susceptibility to antifungal drugs in Cryptococcus neoformans variety grubii isolates from Barcelona city and rural environmental samples.
    Morera-López Y; Torres-Rodríguez JM; Jiménez-Cabello T; Baró-Tomás T; Alía-Aponte C; Lázera MS
    Mycopathologia; 2005 Aug; 160(1):9-14. PubMed ID: 16160762
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Intraspecies diversity of Cryptococcus albidus isolated from humans as revealed by sequences of the internal transcribed spacer regions.
    Sugita T; Takashima M; Ikeda R; Nakase T; Shinoda T
    Microbiol Immunol; 2001; 45(4):291-7. PubMed ID: 11386419
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Molecular identification, antifungal resistance and virulence of Cryptococcus neoformans and Cryptococcus deneoformans isolated in Seville, Spain.
    Gago S; Serrano C; Alastruey-Izquierdo A; Cuesta I; Martín-Mazuelos E; Aller AI; Gómez-López A; Mellado E
    Mycoses; 2017 Jan; 60(1):40-50. PubMed ID: 27633849
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Intraspecies diversity of Cryptococcus laurentii as revealed by sequences of internal transcribed spacer regions and 28S rRNA gene and taxonomic position of C. laurentii clinical isolates.
    Sugita T; Takashima M; Ikeda R; Nakase T; Shinoda T
    J Clin Microbiol; 2000 Apr; 38(4):1468-71. PubMed ID: 10747127
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 10.